Effect Of Complete Decongestive Therapy On Carpal Tunnel Syndrome Post Upper Limb Lymphedema
CDT
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
this study will be conducted to investigate the therapeutic effect of complete decongestive therapy on carpal tunnel syndrome post-upper limb lymphedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2023
CompletedStudy Start
First participant enrolled
July 5, 2023
CompletedFirst Posted
Study publicly available on registry
July 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2023
CompletedJuly 6, 2023
June 1, 2023
3 months
June 27, 2023
June 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
hand strength
hand held dynamometer will be used for measuring the hand strength
up to ten weeks
median nerve conduction velocity
median nerve conduction velocity will be measured by electromyography device
up to ten weeks
Secondary Outcomes (1)
pain intensity
up to ten weeks
Study Arms (2)
Complete decongestive therapy
EXPERIMENTALthe patients will receive complete decongestive therapy twice a week for ten weeks
medical treatment
ACTIVE COMPARATORthe patients will receive routine medical treatment for ten weeks
Interventions
the patients will receive Complete decongestive therapy in the form of intermittent pneumatic compression, Exercising, bandaging, and manual lymphatic drainage with Pressures of 50, 80, and 120 mmHg and timing 5, 20, and 50 secs
the patients will receive routine medical treatment
Eligibility Criteria
You may qualify if:
- Age will range between 20- 40 years.
- Only females will participate in the study.
- All patients have carpal tunnel syndrome post upper limb lymphedema.
You may not qualify if:
- Diabetes mellitus.
- Individuals with cardiopulmonary conditions.
- Individuals undergoing radiation therapy or chemotherapy.
- Hepatic or pancreatic diseases.
- Sensory impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- opaque sealed envelope
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator Sara Abd Elmohsen Ali
Study Record Dates
First Submitted
June 27, 2023
First Posted
July 6, 2023
Study Start
July 5, 2023
Primary Completion
October 5, 2023
Study Completion
October 5, 2023
Last Updated
July 6, 2023
Record last verified: 2023-06